Why the study?
Does the Montreal Cognitive Assessment (MoCA) accurately detect cognitive impairment in chronic hemodialysis patients?
Does the Montreal Cognitive Assessment (MoCA) accurately detect cognitive impairment in chronic hemodialysis patients?
The MoCA is a suitable and sensitive screening tool for detecting cognitive impairment, particularly executive dysfunction, in chronic hemodialysis patients.
May support MoCA screening in hemodialysis; leaves open prospective validation before routine use.
The MoCA represents a suitable cognitive screening tool for hemodialysis patients, demonstrating good sensitivity and specificity levels, and covering executive functions, which appear to play an important role in cognitive performance of HD patients.
No takes yet. Share an insight, caveat, or question.
Tiffin-Richards et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: